Immunology

Items 271-280 of 467

per page
Set Descending Direction
  1. DLK1 (mouse):Fc (human) (rec.)
    AG-40A-0107Y
    AG-40A-0107Y-C01010 µg
    CHF 290.00
    AG-40A-0107Y-30103 x 10 µg
    CHF 575.00
    Replaces AG-40A-0107
    DLK1 (mouse):Fc (human) (rec.)
  2. DLL1 (mouse):Fc (human) (rec.)
    AG-40A-0148Y
    AG-40A-0148Y-C01010 µg
    CHF 180.00
    AG-40A-0148Y-C05050 µg
    CHF 370.00
    DLL1 (mouse):Fc (human) (rec.)
  3. DLL4 (human):Fc (human) (rec.) (highly active mutant)
    AG-40B-0176
    AG-40B-0176-C01010 µg
    CHF 350.00
    AG-40B-0176-C100100 µg
    CHF 1'080.00
    DLL4 (human):Fc (human) (rec.) (highly active mutant) (AG-40B-0176) binds to mNotch1 with higher affinity than WT DLL4:Fc. Method: Notch1 (mouse):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations
  4. DR6 (mouse):Fc (human) (rec.)
    AG-40B-0062
    AG-40B-0062-C05050 µg
    CHF 170.00
    AG-40B-0062-30503 x 50 µg
    CHF 335.00
  5. EDA-A1, Soluble (human) (rec.)
    AG-40B-0106
    AG-40B-0106-C01010 µg
    CHF 205.00
    AG-40B-0106-30103 x 10 µg
    CHF 410.00
  6. EDAR (human):Fc (human) (rec.)
    AG-40B-0116
    AG-40B-0116-C05050 µg
    CHF 290.00
    AG-40B-0116-30503 x 50 µg
    CHF 575.00
  7. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  8. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  9. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper
  10. Fc (human):Dectin-1 (mouse) (rec.)
    AG-40B-0138
    AG-40B-0138-C05050 µg
    CHF 350.00

Items 271-280 of 467

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.